FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Yirrell

Research Profile

Disorders

Living Beings

Geographic Areas

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Charles F Gilks; Pontiano Kaleebu; Ronnie Kasirye; Ben Kikaire; Ivan Mambule; Hellen Musana; Deenan Pillay; Andrew Reid; Val Robertson; Moira Spyer; Francis Ssali; A Sarah Walker; David L Yirrell; David T Dunn; Diana M Gibb
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
Fred Lyagoba; David T Dunn; Deenan Pillay; Cissy Kityo; Val Robertson; Stephano Tugume; James Hakim; Paula Munderi; Mike Chirara; Nicaise Ndembi; Ruth L Goodall; David L Yirrell; Andy Burke; Charles F Gilks; Pontiano Kaleebu
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.
Willie W L Koh; Anna Forsman; Stéphane Hué; Gisela J van der Velden; David L Yirrell; Aine McKnight; Robin A Weiss; Marlén M I Aasa-Chapman
Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Yirrell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Charles F Gilks; Pontiano Kaleebu; Ronnie Kasirye; Ben Kikaire; Ivan Mambule; Hellen Musana; Deenan Pillay; Andrew Reid; Val Robertson; Moira Spyer; Francis Ssali; A Sarah Walker; David L Yirrell; David T Dunn; Diana M Gibb
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
Antiviral therapy 2012;17(7):1363-73.
2010: Fred Lyagoba; David T Dunn; Deenan Pillay; Cissy Kityo; Val Robertson; Stephano Tugume; James Hakim; Paula Munderi; Mike Chirara; Nicaise Ndembi; Ruth L Goodall; David L Yirrell; Andy Burke; Charles F Gilks; Pontiano Kaleebu
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.
Journal of acquired immune deficiency syndromes (1999) 2010;55(2):277-83.
2010: Willie W L Koh; Anna Forsman; Stéphane Hué; Gisela J van der Velden; David L Yirrell; Aine McKnight; Robin A Weiss; Marlén M I Aasa-Chapman
Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes.
The Journal of general virology 2010;91(Pt 9):2374-80.
2010: Nicaise Ndembi; Nicasie Ndembi; Ruth L Goodall; David T Dunn; Adele McCormick; Andy Burke; Fred Lyagoba; Paula Munderi; Pauline Katundu; Cissy Kityo; Val Robertson; David L Yirrell; A Sarah Walker; Diana M Gibb; Charles F Gilks; Pontiano Kaleebu; Deenan Pillay
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
The Journal of infectious diseases 2010;201(1):106-13.
2007: Grant R Campbell; David Senkaali; Jennifer Watkins; Didier Esquieu; Sandrine Opi; David L Yirrell; Pontiano Kaleebu; Erwann P Loret
Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.
Vaccine 2007;25(50):8441-7.
2007: Pontiano Kaleebu; Immaculate L Nankya; David L Yirrell; Leigh Anne Shafer; Jacqueline Kyosiimire-Lugemwa; Daniel B Lule; Dilys Morgan; Simon Beddows; Jonathan Weber; James A G Whitworth
Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort.
Journal of acquired immune deficiency syndromes (1999) 2007;45(1):28-33.
2007: David L Yirrell; E Wright; Leigh Anne Shafer; E Campbell; Lieve Van Der Paal; Pontiano Kaleebu; Heiner Grosskurth; James A G Whitworth
Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in Uganda.
International journal of STD & AIDS 2007;18(4):244-9.
2006: Catherine V Gale; David L Yirrell; Eileen Campbell; Lieve Van Der Paal; Heiner Grosskurth; Pontiano Kaleebu
Genotypic variation in the pol gene of HIV type 1 in an antiretroviral treatment-naive population in rural southwestern Uganda.
AIDS research and human retroviruses 2006;22(10):985-92.
2005: Kirsty M Roy; Syed Ahmed; Sheila O Cameron; L Shaw; David L Yirrell; David Goldberg
Patient notification exercise following a dentist's admission of the periodic use of unsterilized equipment.
The Journal of hospital infection 2005;60(2):163-8.
2005: M Shah Alam; Mohammed S Sarker; Asif Mujtaba Mahmud; A K M Mushfiqur Rahman Faruq; Jahanara Begum; Pierpaolo de Colombani; David L Yirrell; David A Sack; Tasnim Azim
Low HIV infection rates among tuberculosis patients in Dhaka, Bangladesh.
International journal of STD & AIDS 2005;16(1):86-8.
2004: Grant R Campbell; Eddy Pasquier; Jennifer Watkins; Véronique Bourgarel-Rey; Vincent Peyrot; Didier Esquieu; pascale barbier; Jean de Mareuil; Diane Braguer; Pontiano Kaleebu; David L Yirrell; Erwann P Loret
The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.
The Journal of biological chemistry 2004;279(46):48197-204.
2004: David Senkaali; Richard Muwonge; Dilys Morgan; David L Yirrell; Jimmy Whitworth; Pontiano Kaleebu
The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort.
AIDS research and human retroviruses 2004;20(9):932-7.
2004: Sandrine Opi; Jean-Marie Péloponèse; Didier Esquieu; Jennifer Watkins; Grant Campbell; Jean de Mareuil; Kuan-Teh Jeang; David L Yirrell; Pontiano Kaleebu; Erwann P Loret
Full-length HIV-1 Tat protein necessary for a vaccine.
Vaccine 2004;22(23-24):3105-11.
2004: David L Yirrell; L Shaw; S M Burns; Sheila O Cameron; Marlynne Quigg; E Campbell; David Goldberg
HIV-1 subtype in Scotland: the establishment of a national surveillance system.
Epidemiology and infection 2004;132(4):693-8.
2004: Alleluiah Rutebemberwa; Betty Auma; Jill Gilmour; Gareth Jones; David L Yirrell; Samantha Rowland; Nesrina Imami; Christine Watera; Pontiano Kaleebu; Jimmy Whitworth; Frances Gotch
HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans.
AIDS research and human retroviruses 2004;20(7):763-71.
2004: David L Yirrell; Pontiano Kaleebu; Dilys Morgan; Sharon Hutchinson; James A Whitworth
HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort.
International journal of STD & AIDS 2004;15(2):103-6.
2004: Anthony Kebba; Pontiano Kaleebu; Jennifer Serwanga; Samantha Rowland; David L Yirrell; Robert Downing; Jill Gilmour; Nesrina Imami; Frances Gotch; Jimmy Whitworth
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans.
AIDS research and human retroviruses 2004;20(1):67-75.
2002: Sandrine Opi; Jean-Marie Péloponèse; Didier Esquieu; Grant Campbell; Jean de Mareuil; Anne Walburger; Murielle Solomiac; Catherine Grégoire; Emmanuelle Bouveret; David L Yirrell; Erwann P Loret
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants.
The Journal of biological chemistry 2002;277(39):35915-9.
2002: Pontiano Kaleebu; French Neil; Cedric Mahe; David L Yirrell; Christine Watera; Frederick Lyagoba; Jessica Nakiyingi; Alleluiah Rutebemberwa; Dilys Morgan; Jonathan Weber; Charles Gilks; Jimmy Whitworth
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.
The Journal of infectious diseases 2002;185(9):1244-50.
2002: David L Yirrell; Pontiano Kaleebu; Dilys Morgan; Christine Watera; Brian Magambo; Frederick Lyagoba; Jimmy Whitworth
Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda.
AIDS (London, England) 2002;16(2):279-86.
2002: Tasnim Azim; Jozef Bogaerts; David L Yirrell; Akhil C Banerjea; Mohammed S Sarker; Giasuddin Ahmed; Mian M M Amin; A S M Hamidur Rahman; Abu M Z Hussain
Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes.
AIDS (London, England) 2002;16(1):121-3.
2001: Pontiano Kaleebu; Amanda Ross; Dilys Morgan; David L Yirrell; J Oram; Alleluiah Rutebemberwa; Frederick Lyagoba; L Hamilton; Benon Biryahwaho; Jimmy Whitworth
Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.
AIDS (London, England) 2001;15(3):293-9.
2001: Dilys Morgan; Pontiano Kaleebu; Jimmy Whitworth; David L Yirrell; Alleluiah Rutebemberwa; R Shier; B Sebabi; Jill Gilmour; Henry Eotu; N Omoding; Frances Gotch
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda.
International journal of STD & AIDS 2001;12(2):116-21.
2000: Pontiano Kaleebu; David L Yirrell; French Neil; Frederick Lyagoba; Alleluiah Rutebemberwa; R Cheingsong-Popov; Charles Gilks; Benon Biryahwaho; J Weber; Jimmy Whitworth
An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in Uganda.
AIDS research and human retroviruses 2000;16(7):621-5.
1999: David L Yirrell; David J Goldberg; JM Whitelaw; C McSharry; F Raeside; G Codere
Viral subtype and heterosexual acquisition of HIV infections diagnosed in Scotland.
Sexually transmitted infections 1999;75(6):392-5.
1999: David L Yirrell; Sharon J Hutchinson; M Griffin; SM Gore; Andrew J Leigh Brown; David J Goldberg
Completing the molecular investigation into the HIV outbreak at Glenochil prison.
Epidemiology and infection 1999;123(2):277-82.
1999: Sharon J Hutchinson; SM Gore; David J Goldberg; David L Yirrell; J McGregor; AG Bird; Andrew J Leigh Brown
Method used to identify previously undiagnosed infections in the HIV outbreak at Glenochil prison.
Epidemiology and infection 1999;123(2):271-5.
1999: S F Lockett; A Alonso; R Wyld; M P Martin; J Roy Robertson; SM Gore; Clifford Leen; Raymond P Brettle; David L Yirrell; Mary Carrington; Andrew J Leigh Brown
Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.
The Journal of infectious diseases 1999;180(3):614-21.
1998: David L Yirrell; H Pickering; G Palmarini; L Hamilton; A Rutemberwa; Benon Biryahwaho; Jimmy Whitworth; Andrew J Leigh Brown
Molecular epidemiological analysis of HIV in sexual networks in Uganda.
AIDS (London, England) 1998;12(3):285-90.
1997: H Pickering; Martin Okongo; Amato Ojwiya; David L Yirrell; Jimmy Whitworth
Sexual networks in Uganda: mixing patterns between a trading town, its rural hinterland and a nearby fishing village.
International journal of STD & AIDS 1997;8(8):495-500.
1997: David L Yirrell; P Robertson; David J Goldberg; J McMenamin; Sheila Cameron; Andrew J Leigh Brown
Molecular investigation into outbreak of HIV in a Scottish prison.
BMJ (Clinical research ed.) 1997;314(7092):1446-50.
1996: Peter F Nettleton; Janice Gilray; David L Yirrell; G R Scott; Hugh W Reid
Natural transmission of orf virus from clinically normal ewes to orf-naive sheep.
The Veterinary record 1996;139(15):364-6.
1996: D M Haig; G Hutchinson; J Thomson; David L Yirrell; Hugh W Reid
Cytolytic activity and associated serine protease expression by skin and afferent lymph CD8+ T cells during orf virus reinfection.
The Journal of general virology 1996;77 ( Pt 5)():953-61.
1995: P Bird; H T Reyburn; Barbara A Blacklaws; D Allen; Peter F Nettleton; David L Yirrell; NJ Watt; David R Sargan; I McConnell
The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein.
Clinical and experimental immunology 1995;102(2):274-80.
1994: Andrew A Mercer; David L Yirrell; Hugh W Reid; A J Robinson
Lack of cross-protection between vaccinia virus and orf virus in hysterectomy-procured, barrier-maintained lambs.
Veterinary microbiology 1994;41(4):373-82.
1994: David L Yirrell; J P Vestey; Mary Norval
Immune responses of patients to orf virus infection.
The British journal of dermatology 1994;130(4):438-43.
1994: David L Yirrell; Mary Norval; Hugh W Reid
Local epidermal viral infections: comparative aspects of vaccinia virus, herpes simplex virus and human papillomavirus in man and orf virus in sheep.
FEMS immunology and medical microbiology 1994;8(1):1-12.
1991: J P Vestey; David L Yirrell; Mary Norval
What is human catpox/cowpox infection?
International journal of dermatology 1991;30(10):696-8.
1991: David L Yirrell; Hugh W Reid; Mary Norval; G Entrican; Hugh Miller
Response of efferent lymph and popliteal lymph node to epidermal infection of sheep with orf virus.
Veterinary immunology and immunopathology 1991;28(3-4):219-35.
1991: J P Vestey; David L Yirrell; R D Aldridge
Cowpox/catpox infection.
The British journal of dermatology 1991;124(1):74-8.
1990: David L Yirrell; J P Vestey; Mary Norval; R D Aldridge
Human catpox/cowpox infection.
The Veterinary record 1990;127(1):24.
1989: David L Yirrell; Hugh W Reid; Mary Norval; S E Howie
Immune response of lambs to experimental infection with Orf virus.
Veterinary immunology and immunopathology 1989;22(4):321-32.